Risk Stratification for Positive Lymph Nodes in Prostate Cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of endourology

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/end.2007.0129PMID 18393648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy.

  2006cited by this paper
• Robotic extraperitoneal radical prostatectomy: an alternative approach.

  2006cited by this paper
• Extraperitoneal laparoscopic radical prostatectomy: a prospective evaluation of 600 cases.

  2005cited by this paper
• No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.

  2004cited by this paper
• Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute.

  2003cited by this paper
• Laparoscopic radical prostatectomy--an analysis of factors affecting operating time.

  2003cited by this paper
• Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

  2003cited by this paper
• Robotic radical prostatectomy and the Vattikuti Urology Institute technique: an interim analysis of results and technical points.

  2003cited by this paper
• Vattikuti institute prostatectomy: Surgical technique and current results

  2003cited by this paper
• Vattikuti Institute prostatectomy: technique.

  2003cited by this paper
• Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database.

  2002cited by this paper
• Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.

  2002cited by this paper
• Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis.

  2002cited by this paper
• Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.

  2001cited by this paper
• Robotic assisted, laparoscopic pelvic lymph node dissection in humans.

  2001cited by this paper
• Indications for pelvic lymphadenectomy in prostate cancer.

  2001cited by this paper
• Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.

  2000influential reference
• Evaluation of staging lymphadenectomy in prostate cancer.

  1998cited by this paper
• Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer.

  1997cited by this paper
• Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection.

  1995cited by this paper
• Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

  1994cited by this paper

• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging PROSTATE CANCER–PRETREATMENT DETECTION, SURVEILLANCE, AND STAGING Urologic

  2019cites this paper
• ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging.

  2017cites this paper
• ACR Appropriateness Criteria® Prostate Cancer—Pretreatment Detection, Surveillance, and Staging

  2017cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Prostate Cancer–Pretreatment Detection, Surveillance, and Staging

  2016cites this paper
• Câncer de próstata

  2015cites this paper
• Analysis of regional lymph nodes in periprostatic fat following robot‐assisted radical prostatectomy

  2012cites this paper
• Cancer Biomarker Discovery: The Entropic Hallmark

  2010cites this paper